Bausch Health Announces First Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- First Financial to acquire Hickory Point Bank in $111.3M deal
- McKesson reports cybersecurity incident affecting its information systems
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- BioNTech ends colorectal cancer mRNA therapy trial early
Bausch Health Companies (BHC) PT Lowered to $10 at RBC Capital
May 3, 2024 6:36 AM EDTRBC Capital analyst Doug Miehm lowered the price target on Bausch Health Companies (NYSE: BHC) to $10.00 (from $11.00) while maintaining a Sector Perform rating.
The analyst comments "Between Q1 EBITDA that was weaker than expected and little incremental visibility on the BLCO separation... More
